PoliCheck Network
← Back to bills
H.R. 1227119th CongressReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Alternatives to PAIN Act

Introduced: Feb 12, 2025
Latest action: Feb 12, 2025

Latest Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

1
Primary Sponsors
111
Cosponsors
2
Recorded Actions
0
Linked Votes

Plain-English AI Summary

What this bill means

Generated from the official bill text to make the legislation easier to understand.

Not Generated

A plain-English AI summary has not been generated for this bill yet.

Official Summary

Official legislative summary associated with this bill.

Alternatives to Prevent Addiction In the Nation Act or the Alternatives to PAIN Act This bill reduces cost-sharing and prohibits the imposition of certain utilization requirements under the Medicare prescription drug benefit for certain non-opioid pain management drugs. Specifically, the bill requires such drugs to be covered without a deductible and to be placed on the lowest cost-sharing tier (if any). The bill also prohibits the imposition of prior authorization requirements (i.e., requiring prior approval from a plan) or step therapy requirements (i.e., requiring the use of alternative drugs before a drug is covered under a plan) with respect to such drugs.

Primary Sponsors

Members listed as primary sponsors of this legislation.

Cosponsors

Members who joined this legislation as cosponsors.

Mike Kelly

Mike Kelly

Republican • Pennsylvania • District 16

Original Cosponsor

Feb 12, 2025

View profile →

Nanette Diaz Barragán

Nanette Diaz Barragán

Democrat • California • District 44

Original Cosponsor

Feb 12, 2025

View profile →

Jimmy Panetta

Jimmy Panetta

Democrat • California • District 19

Original Cosponsor

Feb 12, 2025

View profile →

John B. Larson

John B. Larson

Democrat • Connecticut • District 1

Feb 24, 2025

View profile →

Carol D. Miller

Carol D. Miller

Republican • West Virginia • District 1

Feb 24, 2025

View profile →

Nicole Malliotakis

Nicole Malliotakis

Republican • New York • District 11

Feb 24, 2025

View profile →

Seth Moulton

Seth Moulton

Democrat • Massachusetts • District 6

Feb 24, 2025

View profile →

Troy Balderson

Troy Balderson

Republican • Ohio • District 12

Mar 18, 2025

View profile →

Michael Guest

Michael Guest

Republican • Mississippi • District 3

Mar 18, 2025

View profile →

Yvette D. Clarke

Yvette D. Clarke

Democrat • New York • District 9

Mar 18, 2025

View profile →

Nikki Budzinski

Nikki Budzinski

Democrat • Illinois • District 13

Mar 18, 2025

View profile →

Ted Lieu

Ted Lieu

Democrat • California • District 36

Mar 24, 2025

View profile →

Charles J. "Chuck" Fleischmann

Charles J. "Chuck" Fleischmann

Republican • Tennessee • District 3

Mar 24, 2025

View profile →

Claudia Tenney

Claudia Tenney

Republican • New York • District 24

Mar 31, 2025

View profile →

Scott H. Peters

Scott H. Peters

Democrat • California • District 50

Mar 31, 2025

View profile →

Jake Auchincloss

Jake Auchincloss

Democrat • Massachusetts • District 4

Apr 7, 2025

View profile →

H. Morgan Griffith

H. Morgan Griffith

Republican • Virginia • District 9

Apr 7, 2025

View profile →

Steve Cohen

Steve Cohen

Democrat • Tennessee • District 9

Apr 28, 2025

View profile →

Glenn Thompson

Glenn Thompson

Republican • Pennsylvania • District 15

Apr 28, 2025

View profile →

Andrea Salinas

Andrea Salinas

Democrat • Oregon • District 6

Jun 3, 2025

View profile →

Tracey Mann

Tracey Mann

Republican • Kansas • District 1

Jun 3, 2025

View profile →

Eleanor Holmes Norton

Eleanor Holmes Norton

Democrat • District of Columbia

Jun 3, 2025

View profile →

Steve Womack

Steve Womack

Republican • Arkansas • District 3

Jun 3, 2025

View profile →

Julia Brownley

Julia Brownley

Democrat • California • District 26

Jun 23, 2025

View profile →

Jennifer A. Kiggans

Jennifer A. Kiggans

Republican • Virginia • District 2

Jun 23, 2025

View profile →

Neal P. Dunn

Neal P. Dunn

Republican • Florida • District 2

Jun 25, 2025

View profile →

Mark Pocan

Mark Pocan

Democrat • Wisconsin • District 2

Jun 25, 2025

View profile →

Robert B. Aderholt

Robert B. Aderholt

Republican • Alabama • District 4

Jun 26, 2025

View profile →

Jill N. Tokuda

Jill N. Tokuda

Democrat • Hawaii • District 2

Jun 26, 2025

View profile →

Gwen Moore

Gwen Moore

Democrat • Wisconsin • District 4

Jun 26, 2025

View profile →

Austin Scott

Austin Scott

Republican • Georgia • District 8

Jun 26, 2025

View profile →

Suhas Subramanyam

Suhas Subramanyam

Democrat • Virginia • District 10

Jul 2, 2025

View profile →

Gus M. Bilirakis

Gus M. Bilirakis

Republican • Florida • District 12

Jul 2, 2025

View profile →

Jim Costa

Jim Costa

Democrat • California • District 21

Jul 10, 2025

View profile →

Earl L. "Buddy" Carter

Earl L. "Buddy" Carter

Republican • Georgia • District 1

Aug 1, 2025

View profile →

Robin L. Kelly

Robin L. Kelly

Democrat • Illinois • District 2

Aug 19, 2025

View profile →

James P. McGovern

James P. McGovern

Democrat • Massachusetts • District 2

Aug 19, 2025

View profile →

Ro Khanna

Ro Khanna

Democrat • California • District 17

Aug 19, 2025

View profile →

Brian J. Mast

Brian J. Mast

Republican • Florida • District 21

Sep 4, 2025

View profile →

Angie Craig

Angie Craig

Democrat • Minnesota • District 2

Sep 8, 2025

View profile →

Eugene Simon Vindman

Eugene Simon Vindman

Democrat • Virginia • District 7

Sep 11, 2025

View profile →

Gabe Vasquez

Gabe Vasquez

Democrat • New Mexico • District 2

Sep 30, 2025

View profile →

Robert P. Bresnahan

Robert P. Bresnahan

Republican • Pennsylvania • District 8

Sep 30, 2025

View profile →

Morgan McGarvey

Morgan McGarvey

Democrat • Kentucky • District 3

Oct 8, 2025

View profile →

Brian K. Fitzpatrick

Brian K. Fitzpatrick

Republican • Pennsylvania • District 1

Oct 10, 2025

View profile →

Donald G. Davis

Donald G. Davis

Democrat • North Carolina • District 1

Oct 31, 2025

View profile →

Robert Garcia

Robert Garcia

Democrat • California • District 42

Nov 20, 2025

View profile →

August Pfluger

August Pfluger

Republican • Texas • District 11

Nov 20, 2025

View profile →

W. Gregory Steube

W. Gregory Steube

Republican • Florida • District 17

Dec 1, 2025

View profile →

Randy K. Sr. Weber

Randy K. Sr. Weber

Republican • Texas • District 14

Dec 2, 2025

View profile →

Aaron Bean

Aaron Bean

Republican • Florida • District 4

Dec 2, 2025

View profile →

John H. Rutherford

John H. Rutherford

Republican • Florida • District 5

Dec 2, 2025

View profile →

John Joyce

John Joyce

Republican • Pennsylvania • District 13

Dec 3, 2025

View profile →

Richard Hudson

Richard Hudson

Republican • North Carolina • District 9

Dec 3, 2025

View profile →

Tim Burchett

Tim Burchett

Republican • Tennessee • District 2

Dec 3, 2025

View profile →

Mike Ezell

Mike Ezell

Republican • Mississippi • District 4

Dec 3, 2025

View profile →

Kat Cammack

Kat Cammack

Republican • Florida • District 3

Dec 4, 2025

View profile →

Emily Randall

Emily Randall

Democrat • Washington • District 6

Dec 5, 2025

View profile →

Troy E. Nehls

Troy E. Nehls

Republican • Texas • District 22

Dec 9, 2025

View profile →

Sylvia R. Garcia

Sylvia R. Garcia

Democrat • Texas • District 29

Dec 9, 2025

View profile →

Madeleine Dean

Madeleine Dean

Democrat • Pennsylvania • District 4

Dec 9, 2025

View profile →

Brittany Pettersen

Brittany Pettersen

Democrat • Colorado • District 7

Dec 9, 2025

View profile →

Ryan Mackenzie

Ryan Mackenzie

Republican • Pennsylvania • District 7

Dec 9, 2025

View profile →

Cliff Bentz

Cliff Bentz

Republican • Oregon • District 2

Dec 9, 2025

View profile →

Terri A. Sewell

Terri A. Sewell

Democrat • Alabama • District 7

Dec 9, 2025

View profile →

Chris Pappas

Chris Pappas

Democrat • New Hampshire • District 1

Dec 9, 2025

View profile →

Sheila Cherfilus-McCormick

Sheila Cherfilus-McCormick

Democrat • Florida • District 20

Dec 9, 2025

View profile →

Pat Harrigan

Pat Harrigan

Republican • North Carolina • District 10

Dec 10, 2025

View profile →

Gabe Amo

Gabe Amo

Democrat • Rhode Island • District 1

Dec 18, 2025

View profile →

Emanuel Cleaver

Emanuel Cleaver

Democrat • Missouri • District 5

Dec 18, 2025

View profile →

Derek Schmidt

Derek Schmidt

Republican • Kansas • District 2

Dec 19, 2025

View profile →

Tom Barrett

Tom Barrett

Republican • Michigan • District 7

Dec 19, 2025

View profile →

Lucy McBath

Lucy McBath

Democrat • Georgia • District 6

Dec 19, 2025

View profile →

John J. McGuire

John J. McGuire

Republican • Virginia • District 5

Jan 7, 2026

View profile →

Michael Lawler

Michael Lawler

Republican • New York • District 17

Jan 13, 2026

View profile →

Shri Thanedar

Shri Thanedar

Democrat • Michigan • District 13

Jan 23, 2026

View profile →

Zoe Lofgren

Zoe Lofgren

Democrat • California • District 18

Feb 9, 2026

View profile →

Adelita S. Grijalva

Adelita S. Grijalva

Democrat • Arizona • District 7

Feb 17, 2026

View profile →

Derrick Van Orden

Derrick Van Orden

Republican • Wisconsin • District 3

Feb 20, 2026

View profile →

Andrew R. Garbarino

Andrew R. Garbarino

Republican • New York • District 2

Mar 4, 2026

View profile →

Salud O. Carbajal

Salud O. Carbajal

Democrat • California • District 24

Mar 16, 2026

View profile →

Lori Trahan

Lori Trahan

Democrat • Massachusetts • District 3

Mar 25, 2026

View profile →

J. Luis Correa

J. Luis Correa

Democrat • California • District 46

Apr 13, 2026

View profile →

John Garamendi

John Garamendi

Democrat • California • District 8

Apr 13, 2026

View profile →

Burgess Owens

Burgess Owens

Republican • Utah • District 4

Apr 16, 2026

View profile →

Kevin Mullin

Kevin Mullin

Democrat • California • District 15

Apr 20, 2026

View profile →

Mike Thompson

Mike Thompson

Democrat • California • District 4

Apr 27, 2026

View profile →

George Whitesides

George Whitesides

Democrat • California • District 27

Apr 27, 2026

View profile →

Ben Cline

Ben Cline

Republican • Virginia • District 6

Apr 30, 2026

View profile →

Robert Menendez

Robert Menendez

Democrat • New Jersey • District 8

May 13, 2026

View profile →

William R. Keating

William R. Keating

Democrat • Massachusetts • District 9

May 20, 2026

View profile →

Josh Gottheimer

Josh Gottheimer

Democrat • New Jersey • District 5

Jun 2, 2026

View profile →

Becca Balint

Becca Balint

Democrat • Vermont

Jun 3, 2026

View profile →

Ashley Hinson

Ashley Hinson

Republican • Iowa • District 2

Jun 4, 2026

View profile →

Sheri Biggs

Sheri Biggs

Republican • South Carolina • District 3

Jun 4, 2026

View profile →

Nikema Williams

Nikema Williams

Democrat • Georgia • District 5

Jun 18, 2026

View profile →

Greg Landsman

Greg Landsman

Democrat • Ohio • District 1

Jun 18, 2026

View profile →

Joseph D. Morelle

Joseph D. Morelle

Democrat • New York • District 25

Jun 18, 2026

View profile →

Mark DeSaulnier

Mark DeSaulnier

Democrat • California • District 10

Jun 18, 2026

View profile →

Cory Mills

Cory Mills

Republican • Florida • District 7

Jun 29, 2026

View profile →

Tim Moore

Tim Moore

Republican • North Carolina • District 14

Jun 29, 2026

View profile →

Don Bacon

Don Bacon

Republican • Nebraska • District 2

Jun 29, 2026

View profile →

Thomas R. Suozzi

Thomas R. Suozzi

Democrat • New York • District 3

Jun 30, 2026

View profile →

Mike Carey

Mike Carey

Republican • Ohio • District 15

Jul 6, 2026

View profile →

Nicholas A. Langworthy

Nicholas A. Langworthy

Republican • New York • District 23

Jul 6, 2026

View profile →

Michael A. Rulli

Michael A. Rulli

Republican • Ohio • District 6

Jul 9, 2026

View profile →

James A. Himes

James A. Himes

Democrat • Connecticut • District 4

Jul 9, 2026

View profile →

Greg Stanton

Greg Stanton

Democrat • Arizona • District 4

Aug 10, 2026

View profile →

Jamie Raskin

Jamie Raskin

Democrat • Maryland • District 8

Aug 10, 2026

View profile →

Sarah McBride

Sarah McBride

Democrat • Delaware

Aug 17, 2026

View profile →

Joe Neguse

Joe Neguse

Democrat • Colorado • District 2

Sep 2, 2026

View profile →

Recorded Actions

Official legislative actions recorded for this measure.

H11100Feb 12, 2025

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Official source ↗
Intro-HFeb 12, 2025

Introduced in House

Official source ↗

Linked Votes

Roll-call votes associated with this legislation.

No roll-call votes are currently linked to this bill.

Lobbying Activity

Federal lobbying disclosures that explicitly identify H.R. 1227. These records show reported lobbying involving the legislation; they do not establish that every member of Congress, sponsor, or voter was personally contacted.

VERTEX PHARMACEUTICALS INCORPORATED

Registrant: STANTON PARK GROUP

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Health Issues: Patient access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; Awareness of Cystic Fibrosis and Sickle Cell Disease; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; HR 1227 and S. 375

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $50,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VERTEX PHARMACEUTICALS INCORPORATED

Registrant: EMPIRE CONSULTING GROUP

2nd Quarter (Apr 1 - June 30)
Jul 16, 2026

Reported lobbying issue

Health Issues: Issues related to HR 1227, Alternatives to Pain Act

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $50,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VERTEX PHARMACEUTICALS INCORPORATED

Registrant: STANTON PARK GROUP

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Health Issues: Patient access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; Awareness of Cystic Fibrosis and Sickle Cell Disease; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; HR 1227 and S. 375

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $50,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VERTEX PHARMACEUTICALS INCORPORATED

Registrant: EMPIRE CONSULTING GROUP

1st Quarter (Jan 1 - Mar 31)
Apr 18, 2026

Reported lobbying issue

Health Issues: HR 1227, Alternatives to PAIN Act.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $50,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VERTEX PHARMACEUTICALS INCORPORATED

Registrant: EMPIRE CONSULTING GROUP

4th Quarter (Oct 1 - Dec 31)
Jan 19, 2026

Reported lobbying issue

Health Issues: HR 1227, Alternatives to PAIN Act.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $30,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VERTEX PHARMACEUTICALS INCORPORATED

Registrant: EMPIRE CONSULTING GROUP

3rd Quarter (July 1 - Sep 30)
Oct 19, 2025

Reported lobbying issue

Health Issues: HR 1227, Alternatives to PAIN Act.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $30,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VERTEX PHARMACEUTICALS INCORPORATED

Registrant: EMPIRE CONSULTING GROUP

2nd Quarter (Apr 1 - June 30)
Jul 18, 2025

Reported lobbying issue

Health Issues: HR 1227, Alternatives to PAIN Act.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $40,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VERTEX PHARMACEUTICALS INCORPORATED

Registrant: EMPIRE CONSULTING GROUP

1st Quarter (Jan 1 - Mar 31)
Apr 18, 2025

Reported lobbying issue

Health Issues: HR 1227, Alternatives to PAIN Act; issues related to CMMIs Cell and Gene Therapy Access model for Sickle Cell Disease.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $50,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VERTEX PHARMACEUTICALS INCORPORATED

Registrant: AVENUE SOLUTIONS

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Medicare/Medicaid: H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; Kidney care issues; FY27 LHHS and Mil-Con appropriations report language Health Issues: Monitor issues related to 340b;

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $60,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN ASSOCIATION OF NURSE PRACTITIONERS

Registrant: AMERICAN ASSOCIATION OF NURSE PRACTITIONERS

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Health Issues: H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act S. 1599/H.R. 6394 - Midwives for Maximizing Optimal Maternity Services (MOMS) Act S. 131/H.R. 392 - Providing Real-world Education and Clinical Experience by Precepting Tomorrows (PRECEPT) Nurses Act H.R. 4564 - Dillons Law H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 3435/H.R. 6607 - Future Advancement of Academic Nursing (FAAN) Act H.R. 1627 - Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 2319/S. 1157 - the Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1261/H.R. 4206 - CONNECT for Health Act for 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act (Restore Act) H.Res. 389/S.Res. 206 - Supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2025. S. 1482/H.R. 4407 - National Nursing Workforce Center Act of 2025 H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 1300 - Prostate-Specific Antigen (PSA) Screening for High-risk Insured Men (HIM) Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 5629 - To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect. H.R. 7787 - Mental Health Workforce Act S. 4186/H.R. 8089 - Perinatal Workforce Act H.R. 7973 - Momnibus Act S. 3707/H.R. 7279 - Nurse Faculty Shortage Reduction Act. H.R. 7602 - State of Men's Health Act H.Res. 1264/S.Res. 709 - Supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2026. H.R. 8163 - the Provider Reimbursement Stability Act H.R. 8261 - Chronic Care Management Improvement Act Affordability of health insurance coverage Tobacco prevention Hospice certification and recertification Immunization policies H.R. 9257/S. 4754 - Primary and Behavioral Health Care Access Act Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Health plan coverage and program requirements, including provider non-discrimination, network adequacy and prior authorization Nursing faculty and workforce shortage Nursing education Include nurses, APRNs, and nursing students in all national public health plans Rural health care issues, including rural workforce and reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic Use of telehealth to prescribe controlled substances under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 [Public Law No: 110-425] Site specific restrictions on providers under DEA controlled substances policy Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records Budget/Appropriations: Appropriations Act, 2027 H.R. 7148 - Consolidated Appropriations Act, 2026 [P.L. No. 119-75] H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Funding for Fiscal Year 2027 for Title VIII Nursing Workforce Development Programs Funding for Fiscal Year 2027 for the National Institute of Nursing Research H.R. 5371 - Continuing Appropriations and Extensions Act, 2026 S. 2882 - Continuing Appropriations and Extensions and Other Matters Act, 2026 H.R. 5304 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] implementation and federal student loan limits Funding for Fiscal Year 2026 for Title VIII Nursing Workforce Development Programs Funding for Fiscal Year 2026 for the National Institute of Nursing Research H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Supporting nursing as a professional degree Issues pertaining to the Department of Education proposal for the professional degree designation of federal student loans Funding for DCD Environmental Health Laboratory for childrens health Support funding for the National Health Service Corps Removal of burdensome Medicare requirements pertaining to nurse practitioners Government Issues: H.R. 4122/S. 2167 - Health Care for Energy Workers Act H.R. 3170/S. 3296 - The Improving Access to Workers Compensation for Injured Federal Workers Act H.R. 2332/S. 1101 - States Handling Access to Reciprocity for Employment (SHARE) Act. Provider neutral language in federal forms, documents and surveys Medicare/Medicaid: H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 1261/H.R. 4206 - CONNECT for Health Act of 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 7787 - Mental Health Workforce Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 7973 - Momnibus Act H.R. 8163 - the Provider Reimbursement Stability Act Hospice certification and recertification Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic Veterans: H.R. 2234 - Ensuring Veterans Timely Access to Anesthesia Care Act S. 3329/H.R. 6203 - U.S. Cadet Nurse Corps Service Recognition Act of 2025 Advanced Practice Nursing full practice authority in the Veterans Health Administration Use of non-opioid therapies in the VA Taxation/Internal Revenue Code: H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 3145/S. 1548 - Nurse Corp Tax Parity Act Taxation of non-profit organizations Education: H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 S. 4568/H.R. 8691 - Nursing is a Professional Degree Act H.R. 6718 - Professional Student Degree Act H.J. Res. 189 / S.J. Res. 196 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Education relating to "Reimagining and Improving Student Education-Federal Student Loan Program Final Regulations" Defense: H.J.Res.149 - Recognizing the 125th anniversary of the Army Nurse Corps, expressing gratitude for members of the Army Nurse Corps for their service to the Nation, and for other purposes. S.Con.Res.27 - A concurrent resolution celebrating the 125th Anniversary of the Army Nurse Corps H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027 H.R. 3170/S. 3296 - Improving Access to Workers Compensation for Injured Federal Workers Act Labor Issues/Antitrust/Workplace: H.R. 8272 - To classify qualified locum tenens professionals and advanced care practitioners as independent contractors for the purposes of the Fair Labor Standards Act of 1938 and the National Labor Relations Act.

Government entities reported: Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES SENATE White House Office Labor, Dept of (DOL) Veterans Affairs, Dept of (VA) Education, Dept of Office of Management & Budget (OMB)

Reported filing-period amount: $400,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN PSYCHIATRIC ASSOCIATION

Registrant: AMERICAN PSYCHIATRIC ASSOCIATION

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Medical/Disease Research/Clinical Labs: APA response to NIH-Wide strategic plan framework for fiscal years 2027-2031 Budget/Appropriations: Fiscal Year 2027 (FY2027) Departments of Labor, Health and Human Services, Education, and Related Agencies appropriations bill Response to OMB proposed rule, Regulation for Federal Financial Assistance Health Issues: H.R. 929/S.266 - Lorna Breen Health Care Provider Protection Reauthorization H.R. 593 - Strengthening Pathways to Health Professions Act H.R. 879/S.1640 - Medicare Patient Access and Practice Stabilization Act H.R. 1153 - Rural America Health Corps Act H.R. 1227/S.475 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 1735/S.779 - EARLY Minds Act H.R. 1448 - PEER for Mental Health Act H.R. 1585/S.709 - Conrad State 30 and Physician Access Reauthorization Act H.R. 1909/S.2621 - Preventing Maternal Deaths Reauthorization Act of 2025 H.R. 957 - Parity Enforcement Act H.R. 2509/S.931 - COMPLETE Care Act H.R. 4206/S.1261 - CONNECT for Health Act H.R. 1305 - Improving Measurements for Loneliness and Isolation Act H.R. 1902 - Helping Emergency Responders Overcome (HERO) Act H.R. 2223 - Building Capacity for Care Act H.R. 2586 - Reentry Act of 2025 H.R. 3884/S.2011 - Telemental Health Care Access Act of 2025 H.R. 3266/S.1673 - Mental Health Infrastructure Improvement Act of 2025 H.R. 4619 - Medicare Mental Health Inpatient Equity Act S. 1062 - Suicide Prevention Act H.R. 912 - 9-8-8 Lifeline Cybersecurity Act H.R. 2587 - Youth Mental Health Research Act H.R. 2483/S.2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 2630 - Youth Suicide Prevention Research Act H.R. 3655 - STAR Plus Scholarship Act H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025 H.R. 3885/S.3989 - Community TEAMS Act H.R. 1867 - To amend title XVIII of the Social Security Act to remove in-person requirements under Medicare for mental health services furnished through telehealth and telecommunications technology H.R. 3164 - Ensuring Community Access to Pharmacist Services (ECAPS) Act H.R. 4681/S. 1379 - Specialty Physicians Advancing Rural Care (SPARC) Act H.R. 4723/S. 2446 - Mental Health for Latinos Act Conversations with Congressional offices on Teaching Health Center Graduate Medical Education (THCGME) H.R.3505 - Barriers to Suicide Act H.R.6249 - Addressing Addiction After Disasters Act H.R.7394/S.3783 - Mental Health Career Promotion Act H.R. 5074 - Protecting Young Minds Online Act H.R. 5434/S. 2826 - 988 LGBTQ+ Youth Access Act H.R.5509 /S.2903 - Safe Step Act H.R. 5557 - Mental Health Services for Students Act H.R.1197 - PREEMIE Reauthorization Act of 2025 H.R. 3514/S.1816 - Improving Seniors Timely Access to Care Act H.Res.792 - Youth Mental Health Day and Suicide Prevention Day Resolution H.R.5725 - Mental Health Crisis Response Act of 2025 H.R.5706 - Mental Health Emergency Responder Act S. 3064 - Relief of Chronic Pain Act H.R. 6226 - Latino Youth Mental Health Empowerment Act H.R. 5482 - Prevent Youth Suicide Act H.R.6672 - Mental Health Professionals Workforce Shortage Loan Repayment Act Letter to Letter to Department of Labor, Department of Health and Human Services, and Department of Treasury regarding mental health parity enforcement H.R. 3492 - Protect Children's Innocence Act H.R. 498 - Do No Harm in Medicaid Act H.R. 6817/ S. 1056 - Home-Based Telemental Health Care Act Communication with Congressional offices on SAMHSA grant terminations Input on Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) modernization Communication with Congressional offices on ghost networks S. 3486 - Expand the Behavioral Health Workforce Now Act H.R.7324/S. 683 - More Behavioral Health Providers Act H.R. 786/S. 1460 - Preserving Patient Access to Accountable Care Act H.R. 4331 - Access to Claims Data Act H.R.5281 - REAL Health Providers Act H.R.7875 - Providing Opportunities for Individuals in Need of Treatment and Support (POINTS) Act Letter to Congress on Agency for Healthcare Research and Quality (AHRQ) funding H.R. 6396 - Kid PROOF Act H.R. 6468 - Rural Residency Planning and Development Act of 2025 H.R. 8234 - Save Money, Save Lives Act H.R.7092 - RAYS Act H.R.7787 - Mental Health Workforce Act Letter in support of funding for gun violence prevention research at CDC, NIH and NIJ. S.4076 - Removing Medicare Mental Health Inpatient Limitations Act of 2026 Letter supporting funding for Maternal Mental Health and Substance Use Disorder Programs (MMHSUD) and National Maternal Mental Health Hotline. H.R. 5629 - To provide that the final rule of the Department of Health and Human Services titled Medications for the Treatment of Opioid Use Disorder except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect H.R. 7994 - The HERO Act H.R. 8124 - STOP Suicide Act S.1924 / H.R.3624 - Improving Mental Health Access for Students Act H.R.8261 - Chronic Care Management Act Letter in support of funding for the Pediatric Mental Health Care Access program H.R. 8201 - Expanding Community Access to Health Services Act Letter supporting increased funding for Childrens Hospital Graduate Medical Education Letter expressing concerns over H.R. 5629 and H.R. 5630 S. 1874 - Title VIII Nursing Workforce Reauthorization Act of 2025 S. 4110 - EMPOWER for Health Act H.R. 9044 - Minority Fellowship Program Reauthorization Act of 2026 H.R. 8163 - Provider Reimbursement Stability Act H.R.8961 - Student Suicide Prevention Awareness Act H.Res.1329 - Expressing support for the designation of May 2026 as Mental Health Awareness Month H.R.8989 - Evidence-Based Youth Suicide Prevention Act of 2026 H.R.8122/ S.4640 - 9-8-8 Connect Act H.R.8811/S.4552 - Moms Matter Act H.R.9257 - Primary and Behavioral Health Care Access Act H.R.8487/S.3401 - Ensuring Excellence in Mental Health Act Joint letter to SAMHSA regarding the planned removal of SAMHSAs buprenorphine practitioner locator and pharmacy locator. Veterans: H.R. 1107 - Protecting Veteran Access to Telemedicine Services Act H.R. 1987/ S. 926 - Saving Our Veterans Lives Act Support for VA physician exemptions to return to office H.R. 3863 - VA Mental Health Outreach and Engagement Act H.R. 4837 - Written Informed Consent Act H.R.8044 - Get Justice-Involved Veterans Behavioral Assistance and Care for Key Health Outcomes to Maintain Empowerment (BACK HOME) Act Medicare/Medicaid: Letter to CMS outlining recommendations for the Medicaid Community Engagement Provisions of H.R.1 Letter to CMS regarding Medicaid and CHIP funding for gender affirming care proposed rule Letter to CMS regarding conditions of participation for gender affirming care proposed rule Response to CMS Medicare Advantage and Medicare Part D 2027 proposed rule Letter to CMS regarding hospital signage guidance Letter to CMS regarding Patient Protection and Affordable Care Act Benefit and Payment Parameters 2027 proposed rule Letter to CMS regarding support for Suicide Safety Planning, and The Collaborative Care Model Letter to CMS in response to RFI on Step Therapy Letter to CMS regarding Interoperability Standards and Prior Authorization proposed rule Letter to CMS regarding Hospital Inpatient Prospective Payment System and Quality Reporting Program 2027 proposed rule Letter to CMS regarding Inpatient Psychiatric Facility Quality Reporting Program and Prospective Payment System 2027 proposed rule Joint letter to HHS, Treasury, and Labor regarding implementation and CMS enforcement of the No Surprises Act Coalition letter to Senator Cassidy, Senator Smith, Representative Tonko, and Representative Huizenga regarding support of Removing Medicare Mental Health Inpatient Limitations Act (S.4076) and the Medicare Mental Health Inpatient Equity Act (H.R. 4619) Joint communication to CMS regarding the implementation of Medicaid eligibility and community engagement requirements under H.R. 1. Education: H.R. 2028/ S. 942 - Resident Education Deferred Interest Act (REDI Act) Letter supporting funding for Mental Health Services Professional Demonstration (MHSP) and School-Based Mental Health Services (SBMH) grant programs Immigration: Letter to DHS Secretary regarding physician J-1 visas Letter to DHS Secretary for physician exemption to H-1B visa fee H.R. 7961 - H-1Bs for Physicians and the Healthcare Workforce Act

Government entities reported: Natl Institutes of Health (NIH) Executive Office of the President (EOP) HOUSE OF REPRESENTATIVES Office of Management & Budget (OMB) SENATE Health & Human Services, Dept of (HHS) Labor, Dept of (DOL) Substance Abuse & Mental Health Services Administration (SAMHSA) Treasury, Dept of Veterans Affairs, Dept of (VA) Centers For Medicare and Medicaid Services (CMS) Education, Dept of Homeland Security, Dept of (DHS)

Reported filing-period amount: $137,391

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VERTEX PHARMACEUTICALS INCORPORATED

Registrant: CGCN GROUP, LLC

2nd Quarter (Apr 1 - June 30)
Jul 19, 2026

Reported lobbying issue

Health Issues: Access to innovative non-opioid medicines. Medicare/Medicaid: Access to innovative non-opioid medicines; Alternatives to PAIN, H.R. 1227; Alternatives to PAIN, S. 475.

Government entities reported: Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES SENATE White House Office

Reported filing-period amount: $50,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VERTEX PHARMACEUTICALS

Registrant: TIBER CREEK GROUP

2nd Quarter (Apr 1 - June 30)
Jul 18, 2026

Reported lobbying issue

Health Issues: Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act. Defense: Issues related to coverage of opioid alternatives.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $60,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN SOCIETY OF ANESTHESIOLOGISTS

Registrant: AMERICAN SOCIETY OF ANESTHESIOLOGISTS

2nd Quarter (Apr 1 - June 30)
Jul 17, 2026

Reported lobbying issue

Medicare/Medicaid: H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025: payment rates H.R. 1317 (2025-2026), I CAN Act: provision of service under Medicare Medicare sequester, PAYGO Medicare Advantage Upcoding Medicare for All/Public Option Historical Medicare payment undervaluation for anesthesiology services (33% problem) Anesthesia Conversion Factor Medicare Physician Fee Schedule Rule Budget neutrality Medicare Economic Index: Medicare inflationary increase Medicaid Bundled payments H.R. 5454/S. 2879 Medicare Advantage Prompt Pay Act WISeR Model Medicare Administrative Contractor (MAC) Local Coverage Determinations (LCD) Practice Expense (PE) Opioid sparing Labor, Health and Human Services (LHHS) Appropriation S.586 - NOPAIN Act: Non-Opioids Prevent Addiction In the Nation Act or the NOPAIN Act Health Issues: Graduate Medical Education Certified Anesthesiologist Assistants Anesthesia workforce shortages HR 3890, Resident Physician Shortage Reduction Act of 2025: residency positions S.709, Conrad State 30 and Physician Access Reauthorization Act: Foreign physician immigration status S. 1380, Specialty Physicians Advancing Rural Care (SPARC) Act: physician shortages in rural areas HR 2028; Resident Education Deferred Interest Act (REDI Act): Student loan relief Anesthesia Research Funding Scope of Practice Merit-based Incentive Payment System, MIPS, MIPS Value Pathway Quality Payment Program, QPP Alternative Payment Model, APM QCDR - Qualified Clinical Data Registry Evaluation and Monitoring codes & cuts Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Brain health CMS Interpretive Guidelines: Hospital Conditions of Participation Related to Anesthesia Services Conditions of Participation - Anesthesia services, opt-outs, supervision CMS: Federal Independent Dispute Resolution (IDR) Process, Batching H.R.27, HALT Fentanyl Act: fentanyl scheduling and registration requirements H.R. 1227/S.475, Alternatives to PAIN Act of 2025: access to non-opioid pain management options Pain Medicine Prescription Drug Abuse CDC Opioid Prescribing Guideline H.R. 3595, Safe Prescribing Through Reporting Act of 2025: disclosure of certain records relating to substance use disorder medications to State prescription drug monitoring programs Drug shortages DEA Scheduling Propofol FDA Safe Use Initiative FDA Operating Room Fires FDA Opioids FDA Network of Experts FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) USP - US Pharmacopeia Compounding NIH Interagency Pain Research Coordinating Committee NIH: Funding, Indirect Costs, Indirect Grants, Overhead Agency for Healthcare Research and Quality (AHRQ) funding Long COVID research 21st Century Cures Initiative Out of Network/Out of Network Payment Network Adequacy Pre-authorization; prior authorization Insurance reform, shared savings, insurer accountability Affordable Care Act reform efforts Provider Nondiscrimination Change Healthcare, Change Healthcare data breach HR 292 Lorna Breen Reauthorization H.R. 3178, SAVE Healthcare Workers Act: To protect hospital personnel from violence, and for other purposes Maternal Mortality/Maternal Care Deserts Blood management 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care S. 2759/H.R. 5283, the Healthcare Workforce Resilience Act, Exemption for Physicians from New H-1B Visa Policy and $100,000 Fee Medical journal fees No Surprises Act (NSA) - H.R.4710 / S. 2420, the No Surprises Enforcement Act H.R. 3164, the Ensuring Community Access to Pharmacist Services Act Advance Premium Tax Credits (APTCs) Federal regulation of commercial health insurance companies One Big Beautiful Bill (OBBB) Commercial payer/payment H.R.7961: H-1Bs for Physicians and the Healthcare Workforce Act S.3822: Breaking Up Big Medicine Act H.R. 4681: Specialty Physicians Advancing Rural Care (SPARC) Act Low-carbon anesthesia OMB Proposed Rule on federal funding / grants U.S. Departments of State and Homeland Security Visa delays Venezuelan patients Pain management in C-sections Veterans: Veterans Affairs Advance Practice Registered Nurses HR 3944, Mil Con VA: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act of 2026 VA Physician/Provider Hiring Federal Supremacy Initiative (National Standards of Practice): reduction in patient safety standard Defense Health Agency (DHA): Physician-led care and scope of practice VHA Directive 1123, National Anesthesia Program/Safe Anesthesia Standards in the VA Defense Health Agency anesthesia policy VA Sterile Processing H.R. 8469: Fiscal 2027 MilCon-VA Funding

Government entities reported: Centers For Medicare and Medicaid Services (CMS) Executive Office of the President (EOP) Government Accountability Office (GAO) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES SENATE Agency for Healthcare Research & Quality (AHRQ) Centers For Disease Control & Prevention (CDC) Defense, Dept of (DOD) Drug Enforcement Administration (DEA) Federal Trade Commission (FTC) Food & Drug Administration (FDA) Justice, Dept of (DOJ) Natl Institutes of Health (NIH) Occupational Safety & Health Administration (OSHA) Office of Management & Budget (OMB) Veterans Affairs, Dept of (VA) White House Office

Reported filing-period amount: $270,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VERTEX PHARMACEUTICALS INCORPORATED

Registrant: VERTEX PHARMACEUTICALS INCORPORATED

2nd Quarter (Apr 1 - June 30)
Jul 16, 2026

Reported lobbying issue

Health Issues: Federal policies impacting pharmaceutical development, approval, and reimbursement; Copay accumulators and maximizers, H.R. 6423/S. 864 - HELP Copays Act; Alternative Funding Programs; Unmet medical need in acute pain; Barriers to patient access of non-opioid pain medicines; General education about kidney disease, including APOL-1 and H.R. 1518 - New Era of Preventing End-Stage Kidney Disease; Cystic Fibrosis; Sickle cell disease; Innovations in Type 1 diabetes treatments. Medicare/Medicaid: Unmet medical need in acute pain; H.R. 1227/S. 475 - The Alternatives to PAIN Act; Implementation of Public Law No: 117-328 sec. 4135 NO PAIN Act; Medically necessary fertility treatments for patients undergoing fully myeloablative conditioning; CMMI demo focusing on sickle cell disease; Drug Pricing Policies including Most Favored Nation policy proposals. Taxation/Internal Revenue Code: Corporate tax reform; H.R. 1414 - Cameron's Law, Preservation of Orphan Drug Tax Credit. Budget/Appropriations: Education about non-opioid pain therapies and patient access to non-opioid medicines, updates on coverage progress at the VHA and CMS. Veterans: Issues related to veteran's access to non-opioid alternatives and implementation of report language in the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37). Defense: Issues related to the Defense Health Agency and service member access to non-opioid alternatives, including reinstating the DHA Benefits Advisory Panel and the structured formulary management process. District of Columbia: Issues related to Sec. 232 pharmaceutical tariffs, onshoring active pharmaceutical ingredients (API), and supply chain disruptions for products related to the opioid public health emergency.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE Centers For Medicare and Medicaid Services (CMS) Congressional Budget Office (CBO) Food & Drug Administration (FDA) Health & Human Services, Dept of (HHS) Office of Management & Budget (OMB) Vice President of the U.S. White House Office Commerce, Dept of (DOC)

Reported filing-period amount: $1,200,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

PRIME THERAPEUTICS

Registrant: PRIME THERAPEUTICS

2nd Quarter (Apr 1 - June 30)
Jul 16, 2026

Reported lobbying issue

Health Issues: H.R. 7148 (now Public Law 119-75) The Consolidated Appropriations Act provisions regulating pharmacy benefit manager practices S. 2355 Patients Deserve Price Tags Act provisions related to drug price transparency and patient transparency tools S. 3822 Break Up Big Medicine Act provisions related to insurer/PBM ownership or pharmacies S. 1954/HR 5526 The Biosimilar Red Tape Elimination Act - provisions related to interchangeability of biosimilars Department of Labors Notice of Proposed Rulemaking, Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure (RIN 1210-AB37) H.R.9393 Lower Costs, More Transparency Act of 2026 Medicare/Medicaid: H.R. 8143 Ensuring Access to Lower Cost Medicines for Seniors Act of 2026 provisions related to formulary placement of certain drugs. H.R. 7148 (now Public Law 119-75) The Consolidated Appropriations Act provisions regulating pharmacy benefit manager practices H.R. 1227, Alternatives to PAIN Act requirements related to formulary Tierring and prior authorization in Medicare Part D for non-opioid pain medications.

Government entities reported: HOUSE OF REPRESENTATIVES Labor, Dept of (DOL) SENATE

Reported filing-period amount: $100,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VERTEX PHARMACEUTICALS INCORPORATED

Registrant: MARSHALL & POPP, LLC

2nd Quarter (Apr 1 - June 30)
Jul 9, 2026

Reported lobbying issue

Medicare/Medicaid: Issues related to pain management, including S.475/H.R. 1227 - Alternatives to PAIN Act. Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to FDA regulation of pharmaceuticals. Trade (domestic/foreign): Issues related to tariff and trade policy.

Government entities reported: Centers For Medicare and Medicaid Services (CMS) HOUSE OF REPRESENTATIVES SENATE White House Office Natl Economic Council (NEC)

Reported filing-period amount: $60,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN PSYCHIATRIC ASSOCIATION

Registrant: AMERICAN PSYCHIATRIC ASSOCIATION

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Budget/Appropriations: Fiscal Year 2026 (FY2026) Departments of Labor, Health and Human Services, Education, and Related Agencies appropriations bill Fiscal Year 2027 (FY2027) Departments of Labor, Health and Human Services, Education, and Related Agencies appropriations bill Health Issues: H.R.1096 - HOPE and Mental Wellbeing Act of 2025 H.R. 929/S. 266 - Lorna Breen Health Care Provider Protection Reauthorization H.R. 593 - Strengthening Pathways to Health Professions Act H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act H.R. 1153 - Rural America Health Corps Act H.R. 1227/S. 475 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 1735/S. 779 - EARLY Minds Act H.R. 1448 - PEER for Mental Health Act H.R. 1585/S. 709 - Conrad State 30 and Physician Access Reauthorization Act H.R. 1909/S. 2621 - Preventing Maternal Deaths Reauthorization Act of 2025 H.R. 957 - Parity Enforcement Act H.R. 2509/S. 931 - COMPLETE Care Act H.R. 4206/S. 1261 - CONNECT for Health Act H.R. 1305 - Improving Measurements for Loneliness and Isolation Act H.R. 1902 - Helping Emergency Responders Overcome (HERO) Act H.R. 2223 - Building Capacity for Care Act H.R. 2586 - Reentry Act of 2025 H.R. 3884/S.2011 - Telemental Health Care Access Act of 2025 H.R. 3266/S.1673 - Mental Health Infrastructure Improvement Act of 2025 Mental Health Matters Act H.R. 4619 - Medicare Mental Health Inpatient Equity Act S. 1062 - Suicide Prevention Act H.R. 912 - 9-8-8 Lifeline Cybersecurity Act H.R. 2587 - Youth Mental Health Research Act H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 2630 - Youth Suicide Prevention Research Act H.R. 3655 - STAR Plus Scholarship Act H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025 H.R. 3885/S.3989 - Community TEAMS Act H.R. 1867 - To amend title XVIII of the Social Security Act to remove in-person requirements under Medicare for mental health services furnished through telehealth and telecommunications technology H.R. 3164 - Ensuring Community Access to Pharmacist Services (ECAPS) Act H.R. 4681/S. 1379 - Specialty Physicians Advancing Rural Care (SPARC) Act H.R. 4723/S. 2446 - Mental Health for Latinos Act Conversations with Congressional offices on Teaching Health Center Graduate Medical Education (THCGME) H.R.3505 - Barriers to Suicide Act Letters to Congress to extend the enhanced premium tax credits H.R.6249 - Addressing Addiction After Disasters Act H.R.7394/S.3783 - Mental Health Career Promotion Act H.R. 5074 - Protecting Young Minds Online Act H.R. 5434/S. 2826 - 988 LGBTQ+ Youth Access Act H.R.5509 /S.2903 - Safe Step Act H.R. 5557 - Mental Health Services for Students Act H.R.1197 - PREEMIE Reauthorization Act of 2025 H.R. 3514/S.1816 - Improving Seniors Timely Access to Care Act H.Res.792 - Youth Mental Health Day and Suicide Prevention Day Resolution H.R.5725 - Mental Health Crisis Response Act of 2025 H.R.5706 - Mental Health Emergency Responder Act S. 3064 - Relief of Chronic Pain Act H.R. 6226 - Latino Youth Mental Health Empowerment Act H.R. 5482 - Prevent Youth Suicide Act H.R.6672 - Mental Health Professionals Workforce Shortage Loan Repayment Act Letter to Letter to Department of Labor, Department of Health and Human Services, and Department of Treasury regarding mental health parity enforcement H.R. 3492 - Protect Children's Innocence Act H.R. 498 - Do No Harm in Medicaid Act H.R. 6817/ S. 1056 - Home-Based Telemental Health Care Act Communication with Congressional offices on SAMHSA grant terminations Input on Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) modernization Communication with Congressional offices on ghost networks S. 3486 - Expand the Behavioral Health Workforce Now Act H.R.7324/S. 683 - More Behavioral Health Providers Act H.R. 786/S. 1460 - Preserving Patient Access to Accountable Care Act H.R. 4331 - Access to Claims Data Act H.R.5281 - REAL Health Providers Act H.R.7875 - Providing Opportunities for Individuals in Need of Treatment and Support (POINTS) Act Response to HHS proposed rule on nondiscrimination on the basis of disability Letter to Congress on Agency for Healthcare Research and Quality (AHRQ) funding H.R. 6396 - Kid PROOF Act H.R. 6468 - Rural Residency Planning and Development Act of 2025 H.R. 8234 - Save Money, Save Lives Act H.R.7092 - RAYS Act H.R.7787 - Mental Health Workforce Act Letter in support of funding for gun violence prevention research at CDC, NIH and NIJ. S.4076 - Removing Medicare Mental Health Inpatient Limitations Act of 2026 Letter supporting funding for Maternal Mental Health and Substance Use Disorder Programs (MMHSUD) and National Maternal Mental Health Hotline. H.R. 5629 - To provide that the final rule of the Department of Health and Human Services titled Medications for the Treatment of Opioid Use Disorder except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect H.R. 7994 - The HERO Act Veterans: H.R. 1107 - Protecting Veteran Access to Telemedicine Services Act H.R. 1987/ S. 926 - Saving Our Veterans Lives Act Support for VA physician exemptions to return to office H.R. 3863 - VA Mental Health Outreach and Engagement Act H.R. 4837 - Written Informed Consent Act Get Justice-Involved Veterans Behavioral Assistance and Care for Key Health Outcomes to Maintain Empowerment (BACK HOME) Act Medicare/Medicaid: Letter to CMS outlining recommendations for the Medicaid Community Engagement Provisions of H.R.1 Letter to CMS regarding Medicaid and CHIP funding for gender affirming care proposed rule Letter to CMS regarding conditions of participation for gender affirming care proposed rule Response to CMS Medicare Advantage and Medicare Part D 2027 proposed rule Letter to CMS regarding hospital signage guidance Letter to CMS regarding Patient Protection and Affordable Care Act Benefit and Payment Parameters 2027 proposed rule Letter to CMS regarding support for Suicide Safety Planning, and The Collaborative Care Model Education: H.R. 2028/ S. 942 - Resident Education Deferred Interest Act (REDI Act) Letter to Department of Education to preserve federal loan exception that allows medical students and other health professions to borrow additional Unsubsidized Direct loans Letter to Department of Education regarding proposed amendments to federal student loan limits Letter supporting funding for Mental Health Services Professional Demonstration (MHSP) and School-Based Mental Health Services (SBMH) grant programs Immigration: Letter to DHS Secretary regarding physician J-1 visas Letter to DHS Secretary for physician exemption to H-1B visa fee H.R. 7961 - H-1Bs for Physicians and the Healthcare Workforce Act Medical/Disease Research/Clinical Labs: APA Letter to the CDC on the extension of the Maternal Mortality Review Information Application

Government entities reported: Executive Office of the President (EOP) HOUSE OF REPRESENTATIVES SENATE Food & Drug Administration (FDA) Health & Human Services, Dept of (HHS) Labor, Dept of (DOL) Substance Abuse & Mental Health Services Administration (SAMHSA) Treasury, Dept of Veterans Affairs, Dept of (VA) Centers For Medicare and Medicaid Services (CMS) Education, Dept of Homeland Security, Dept of (DHS) Centers For Disease Control & Prevention (CDC)

Reported filing-period amount: $205,809

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VERTEX PHARMACEUTICALS INCORPORATED

Registrant: AVENUE SOLUTIONS

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Health Issues: Monitor issues related to 340b; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC) Medicare/Medicaid: H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $60,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VERTEX PHARMACEUTICALS INCORPORATED

Registrant: CGCN GROUP, LLC

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Health Issues: Access to innovative non-opioid medicines. Medicare/Medicaid: Access to innovative non-opioid medicines; Alternatives to PAIN, H.R. 1227; Alternatives to PAIN, S. 475.

Government entities reported: Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES SENATE White House Office

Reported filing-period amount: $80,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

Registrant: AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Insurance: Support for the Dental and Optometric Care (DOC) Access Act (HR 1521), which would prohibit dental and vision plans from capping fees on non-covered services Support for the Improving Dental Administration Act (HR 7931), which would apply state dental insurance laws to ERISA dental plans operating in that state. Support for reintroduction of the Ensuring Lasting Smiles Act (S 1677/HR 3277), which would require health insurers to cover treatment, including dental, for patients with congenital craniofacial anomalies. Education: Support for the Resident Education Deferred (REDI) Act (HR 2028/S 942), which would allow physicians and dentists to defer their student loans interest free during residency. Comments on the Reimagining and Improving Student Education Notice of Proposed Rulemaking; RIN 1840-AD98 Medicare/Medicaid: Support for legislative efforts to provide long term reform to the Medicare physician payment system as well as repeal the 2.5 precent efficiency cut scheduled for CY 2026. Comments in response to the proposed rule, Patient Protection and Affordable Care Act (ACA); Notice of Benefit and Payment Parameters for 2027 that opposes reinstating the prohibition on non-pediatric dental services as an essential health benefit. Health Issues: -Support for the RAPID Reserve Act (S 2062/HR 3955), which aims to address drug shortages by awarding federal contracts to American-based manufacturers of generic drugs to encourage domestic production of these critical medications as well as incentivize them to increase their reserves in preparation for possible future public health threats or supply chain challenges and ramp up their production capacity if necessary to proactively prevent shortages. -Support for the Mapping Americas Pharmaceutical Supply or MAPS Act (S 1784/HR 4191), which seeks conduct a risk assessment and supply chain map of all essential medicines to help identify vulnerabilities and potential national security risks. -Support for the Drug Shortages Prevention Act (S 2665), which would have required manufacturers to notify the FDA of heightened demand for crucial medicines that could lead to shortages -Support for the reintroduction of the following bill from the 118th Congress: The Drug Shortages Prevention and Quality Improvement Act, which aimed to implement reimbursement models to incentivize the production of generic injectables and extend expiration dates for lifesaving medications -Comments in response to the notice of proposed rulemaking (ANPRM) Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals. -Encouraging congressional assistance to seek information from the Defense Health Agency, which administers the Tricare program, on the rates used to reimburse participating providers in the TRICARE Active Duty Dental Program (ADDP). -Support for FY 2027 appropriations for the Dr. Lorna Breen Health Care Provider Protection Act. -Support for the Alternatives to Prevent Addiction in the Nation Act (H.R. 1227), which would reduce cost-sharing and prohibits the imposition of certain utilization requirements under the Medicare prescription drug benefit for certain non-opioid pain management drugs. -Urging CMS to communicate to Part D plan sponsors about the clinical importance of FDA-approved, clinically appropriate non-opioid acute pain treatment options and encourage appropriate formulary coverage ensuring beneficiary access to such approaches.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE Education, Dept of Centers For Medicare and Medicaid Services (CMS) Defense, Dept of (DOD)

Reported filing-period amount: $50,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN ASSOCIATION OF NURSE PRACTITIONERS

Registrant: AMERICAN ASSOCIATION OF NURSE PRACTITIONERS

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Health Issues: H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act S. 1599 - Midwives for Maximizing Optimal Maternity Services (MOMS) Act S. 131/H.R. 392 - Providing Real-world Education and Clinical Experience by Precepting Tomorrows (PRECEPT) Nurses Act H.R. 4564 - Dillons Law H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 3435/H.R. 6607 - Future Advancement of Academic Nursing (FAAN) Act H.R. 1627 - Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 2319/S. 1157 - the Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1261/H.R. 4206 - CONNECT for Health Act for 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act (Restore Act) H.Res. 389/S.Res. 206 - Supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2025. S. 1482 - National Nursing Workforce Center Act of 2025 H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 1300 - Prostate-Specific Antigen (PSA) Screening for High-risk Insured Men (HIM) Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 5629 - To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect. H.R. 7787 - Mental Health Workforce Act S. 4186/H.R. 8089 - Perinatal Workforce Act H.R. 7973 - Momnibus Act S. 3707/H.R. 7279 - Nurse Faculty Shortage Reduction Act. H.R. 7602 - State of Men's Health Act Chronic Care Management Improvement Act Affordability of health insurance coverage Tobacco prevention Hospice certification and recertification Immunization policies Primary and Behavioral Health Care Access Act Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Health plan coverage and program requirements, including provider non-discrimination, network adequacy and prior authorization Nursing faculty and workforce shortage Nursing education Include nurses, APRNs, and nursing students in all national public health plans Rural health care issues, including rural workforce and reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic Use of telehealth to prescribe controlled substances under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 [Public Law No: 110-425] Site specific restrictions on providers under DEA controlled substances policy Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records Budget/Appropriations: H.R. 7148 - Consolidated Appropriations Act, 2026 [P.L. No. 119-75] H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Funding for Fiscal Year 2027 for Title VIII Nursing Workforce Development Programs Funding for Fiscal Year 2027 for the National Institute of Nursing Research H.R. 5371 - Continuing Appropriations and Extensions Act, 2026 S. 2882 - Continuing Appropriations and Extensions and Other Matters Act, 2026 H.R. 5304 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] Funding for Fiscal Year 2026 for Title VIII Nursing Workforce Development Programs Funding for Fiscal Year 2026 for the National Institute of Nursing Research H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. Issues pertaining to the Department of Education proposal for the professional degree designation of federal student loans Funding for DCD Environmental Health Laboratory for childrens health Support funding for the National Health Service Corps Removal of burdensome Medicare requirements pertaining to nurse practitioners Government Issues: H.R. 4122/S. 2167 - Health Care for Energy Workers Act H.R. 3170/S. 3296 - The Improving Access to Workers Compensation for Injured Federal Workers Act Provider neutral language in federal forms, documents and surveys Medicare/Medicaid: H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 1261/H.R. 4206 - CONNECT for Health Act of 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 7787 - Mental Health Workforce Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 7973 - Momnibus Act Hospice certification and recertification Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic Veterans: H.R. 2234 - Ensuring Veterans Timely Access to Anesthesia Care Act Advanced Practice Nursing full practice authority in the Veterans Health Administration Use of non-opioid therapies in the VA Taxation/Internal Revenue Code: H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 3145/S. 1548 - Nurse Corp Tax Parity Act Taxation of non-profit organizations Education: H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 Issues pertaining to the Department of Education proposal for the professional degree designation of federal student loans Defense: H.J.Res.149 - Recognizing the 125th anniversary of the Army Nurse Corps, expressing gratitude for members of the Army Nurse Corps for their service to the Nation, and for other purposes. S.Con.Res.27 - A concurrent resolution celebrating the 125th Anniversary of the Army Nurse Corps

Government entities reported: Centers For Medicare and Medicaid Services (CMS) Drug Enforcement Administration (DEA) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES SENATE White House Office Labor, Dept of (DOL) Veterans Affairs, Dept of (VA) Education, Dept of Office of Management & Budget (OMB)

Reported filing-period amount: $400,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

PRIME THERAPEUTICS

Registrant: PRIME THERAPEUTICS

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Health Issues: H.R. 7148 (now Public Law 119-75) The Consolidated Appropriations Act provisions regulating pharmacy benefit manager practices S. 2355 Patients Deserve Price Tags Act provisions related to drug price transparency and patient transparency tools S. 3822, Break Up Big Medicine Act provisions related to insurer/PBM ownership or pharmacies S. 1954/HR 5526 The Biosimilar Red Tape Elimination Act -provisions related to interchangeability of biosimilars Department of Labors Notice of Proposed Rulemaking, Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure (RIN 1210-AB37). Medicare/Medicaid: H.R. 8143 Ensuring Access to Lower Cost Medicines for Seniors Act of 2026 provisions related to formulary placement of certain drugs. H.R. 7148 (now Public Law 119-75) The Consolidated Appropriations Act provisions regulating pharmacy benefit manager practices H.R. 1227, Alternatives to PAIN Act requirements related to formulary Tierring and prior authorization in Medicare Part D for non-opioid pain medications.

Government entities reported: HOUSE OF REPRESENTATIVES Labor, Dept of (DOL) SENATE

Reported filing-period amount: $120,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VERTEX PHARMACEUTICALS

Registrant: TIBER CREEK GROUP

1st Quarter (Jan 1 - Mar 31)
Apr 19, 2026

Reported lobbying issue

Health Issues: Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act. Defense: Issues related to coverage of opioid alternatives.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $60,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

VERTEX PHARMACEUTICALS INCORPORATED

Registrant: VERTEX PHARMACEUTICALS INCORPORATED

1st Quarter (Jan 1 - Mar 31)
Apr 17, 2026

Reported lobbying issue

Health Issues: Federal policies impacting pharmaceutical development, approval, and reimbursement; Copay accumulators and maximizers, H.R. 6423/S. 864 - HELP Copays Act; Alternative Funding Programs; Unmet medical need in acute pain; Barriers to patient access of non-opioid pain medicines; General education about kidney disease, including APOL-1 and H.R. 1518 - New Era of Preventing End-Stage Kidney Disease; Cystic Fibrosis; Sickle cell disease; Innovations in Type 1 diabetes treatments. Medicare/Medicaid: Unmet medical need in acute pain; H.R. 1227/S. 475 - The Alternatives to PAIN Act; Implementation of Public Law No: 117-328 sec. 4135 NO PAIN Act; Medically necessary fertility treatments for patients undergoing fully myeloablative conditioning; CMMI demo focusing on sickle cell disease; Drug Pricing Policies including Most Favored Nation policy proposals. Taxation/Internal Revenue Code: Corporate tax reform; H.R. 1414 - Cameron's Law, Preservation of Orphan Drug Tax Credit. Budget/Appropriations: Education about non-opioid pain therapies and patient access to non-opioid medicines, updates on coverage progress at the VHA and CMS. Trade (domestic/foreign): Intellectual property reforms to address unfair trade practices in Argentina and Russia. Veterans: Issues related to veteran's access to non-opioid alternatives and implementation of report language in the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37). Defense: Issues related to the Defense Health Agency and service member access to non-opioid alternatives, including reinstating the DHA Benefits Advisory Panel and the structured formulary management process.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE Centers For Medicare and Medicaid Services (CMS) Congressional Budget Office (CBO) Food & Drug Administration (FDA) Health & Human Services, Dept of (HHS) Office of Management & Budget (OMB) Vice President of the U.S. White House Office U.S. Trade Representative (USTR)

Reported filing-period amount: $1,140,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

Showing the 25 most recent matching disclosures.

Discussion notificationsSign in to subscribe
?
No comments yet. Start the conversation.